在胃癌中,NFS1通过调节STAT3通路来抑制铁
You Jiang1,2, Liqiang Li2, Wenbo Li1,2
1Department of General Surgery, First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Shushan District, Hefei City, 230022, Anhui Province, P.R. China.
Journal of bioenergetics and biomembranes
|September 10, 2024
概括
囊脱硫酶 (NFS1) 在胃癌 (GC) 中表达高,与预后不佳相关. 通过激活STAT3通路,NFS1抑制铁,这表明NFS1是GC的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 囊脱硫酶 (NFS1) 涉及各种瘤和铁亡.
- 对于NFS1在胃癌 (GC) 发展中的作用及其潜在机制尚不清楚.
研究的目的:
- 为了研究NFS1在GC组织和细胞中的表达.
- 阐明NFS1,铁亡和GC中的STAT3信号通路之间的关系.
- 评估NFS1作为潜在的预后生物标志物和GC的治疗目标.
主要方法:
- 在GC组织和细胞系中对NFS1表达的定量分析.
- 在体外研究中,使用siRNA在GC细胞中进行了NFS1敲击.
- 细胞活力,迁移,入侵和铁亡标志物 (ROS,Fe2+,MDA) 的评估.
- 研究STAT3信号通路及其下游目标 (GPX4,SLC7A11).
- 在体内验证使用老鼠异种移植瘤模型.
主要成果:
- 与正常对应物相比,NFS1表达在GC组织和细胞中显著升高.
- 高NFS1表达与GC患者的整体存活率较低相关.
- 抑制NFS1降低了GC细胞的活力,迁移和入侵,同时促进了铁亡.
- 通过上调STAT3通路的调节,NFS1抑制铁亡,导致GPX4和SLC7A11表达的减少.
- 缺少NFS1会增加ROS,Fe2+和MDA水平,这表明铁亡.
- 通过STAT3激活,可以逆转NFS1缺陷对ferroptosis的影响.
- 在体内实验证实了NFS1在铁亡中的抑制作用及其与瘤生长的关联.
结论:
- NFS1在GC中过度表达,并作为预后生物标志物.
- NFS1通过激活STAT3信号通路来抑制GC中的铁亡.
- 准NFS1代表了胃癌的潜在治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


